{"id":"9f338ad3-7cda-4921-8677-889a674d24d2","arxiv_id":"2508.11063","paper_version":1,"verdict":"UNVERDICTED","confidence":"LOW","novelty_score":4.0,"correctness_risk":"unknown","formal_verification":"none","parameter_count":1,"one_line_summary":"The abstract proposes that abdominal fat and pancreas characteristics are consistent type 2 diabetes markers in lean, overweight, and obese CT cohorts, but the provided full text does not match this study.","lead":"This preprint's abstract describes a machine-learning study linking CT-based abdominal body composition to type 2 diabetes across weight groups, finding shared signatures such as fatty muscle and a smaller fat-laden pancreas. The full text provided, however, is a different manuscript on AI bias, so the research cannot be evaluated as presented.","discovery_kind":"new_application","skeptic_critique":{"model":"deepseek-v4-flash","headline":"The abstract describes a CT phenotype study, but the full text is an unrelated AI-bias literature review; the central claim therefore has no accompanying methods or results to verify.","rationale":"The reader correctly identified the abstract/full-text mismatch in their rationale and set the verdict to UNVERDICTED. However, their declared weakest_assumption was CT measurement accuracy, which presupposes that the study exists. The more load-bearing concern is the complete absence of the study itself: without the methods and results, no claim can be evaluated. This does not change the verdict because UNVERDICTED remains the appropriate outcome, but it sharpens the reason. If the correct manuscript is eventually provided, then the measurement-accuracy concern would become central. My response agrees with the reader's overall verdict but differs on where the weakest point lies.","tokens_in":2096,"tokens_out":2102,"duration_ms":21530,"concrete_test":"Download the full PDF of arXiv:2508.11063 and search the body text (excluding the abstract) for 'CT', 'diabetes', 'random forest', and 'SHAP'. If none of these terms appear in the methods or results sections, the central claim has no supporting manuscript and the verdict stays UNVERDICTED.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim—that abdominal drivers of type 2 diabetes are consistent across weight classes—is asserted in the abstract but is entirely unsupported by the manuscript body. The full text is Ghosh and Wilson's literature review on AI/LLM bias, with no mention of CT imaging, diabetes cohorts, random forests, SHAP, or any of the abstract's analyses. There is no way to audit the segmentation, cohort definitions, cross-validation, or statistical tests that the abstract reports. Because the evidence base is missing, every secondary concern (e.g., CT measurement validity, confound control) is moot; the study itself is not present. This is not a stylistic inconsistency but an absent method/results section, making the claim unverifiable.","agreement_with_reader":"partial"},"referee_report":{"model":"deepseek-v4-flash","summary":"The manuscript, as submitted, presents a title and abstract for a study titled \"Data-Driven Abdominal Phenotypes of Type 2 Diabetes in Lean, Overweight, and Obese Cohorts,\" which claims to use automated CT segmentation, random forests, SHAP attribution, and clustering to identify abdominal body-composition signatures of type 2 diabetes in BMI subgroups. The abstract reports cross-validated AUCs of 0.72–0.74 and univariate logistic-regression confirmation of top predictors. However, the full text provided is a different, unrelated paper: a systematic literature review of AI/LLM bias by Ghosh and Wilson. That body contains no mention of CT imaging, diabetes, abdominal phenotypes, random forests, SHAP, or any of the analyses described in the abstract. The central claim of the abstract is therefore entirely unsupported by the manuscript body.","tokens_in":2193,"tokens_out":2267,"duration_ms":25551,"significance":"If the study described in the abstract existed and were properly validated, the finding that abdominal drivers of type 2 diabetes are consistent across weight classes would be a worthwhile contribution to body-composition phenotyping and could inform risk-stratification efforts. The paper also outlines a plausible explainable-AI workflow (classify, attribute, cluster, verify) that is of methodological interest. However, none of this is present in the manuscript body. The provided full text is an unrelated literature review, so the claimed study cannot be evaluated on any of its technical merits: cohort construction, segmentation accuracy, model validation, feature definition, or statistical testing are all unverifiable. The scientific contribution asserted in the abstract is not supported by any accompanying evidence.","major_comments":[{"comment":"The entire body of the manuscript is Ghosh and Wilson's \"Bias is a Math Problem, AI Bias is a Technical Problem: 10-year Literature Review of AI/LLM Bias Research Reveals Narrow [Gender-Centric] Conceptions of 'Bias', and Academia-Industry Gap,\" a literature review of fairness research in *ACL, FAccT, NeurIPS, and AAAI. This text contains no discussion of CT imaging, type 2 diabetes, body composition, random forests, SHAP, clustering, or cohorts of lean/overweight/obese patients. The abstract's \"Approach,\" \"Results,\" and \"Conclusions\" therefore have no corresponding methods, data, or results in the manuscript. This is not a stylistic inconsistency but an absent evidence base: the central claim that abdominal drivers of type 2 diabetes are consistent across weight classes is asserted in the abstract and nowhere supported.","section":"Full Text (all sections, from §1 Introduction onward)"},{"comment":"The abstract reports specific quantitative claims—cohort sizes (n = 1,728 full; 497 lean; 611 overweight; 620 obese), mean AUCs of 0.72–0.74, SHAP-derived feature contributions, clustering of scans, and univariate logistic-regression confirmation of 14–18 of the top 20 predictors (p < 0.05)—but none of these numbers can be audited because the manuscript body lacks the study. There is no description of the CT segmentation method or its validation, no definition of the features (e.g., \"fatty skeletal muscle\"), no cross-validation protocol, no feature list, and no statistical analysis section. Every load-bearing methodological detail is missing, making the reported results unverifiable.","section":"Abstract (Approach and Results)"},{"comment":"The title and abstract describe a cs.CV medical-imaging study, while the body is a cs.CY fairness-review paper with different authors, different affiliations, and different research questions. The manuscript is internally inconsistent in a way that cannot be remedied by local revisions: either the submitted full text is the wrong file, or the abstract is fabricated. Under either interpretation, the present version cannot be published as a coherent scientific paper.","section":"Full Text (relevance and internal consistency)"}],"minor_comments":[{"comment":"The abstract uses the phrase \"fatty skeletal muscle\" without defining whether it denotes intramuscular fat, intermuscular fat, or radiodensity-based myosteatosis; in a field where such definitions vary, a precise definition would be needed if the study were present.","section":"Abstract (terminology)"},{"comment":"The body's references and venue names (e.g., FAccT, AAAI) are entirely unrelated to the abstract's topic; any reader attempting to follow the abstract's claims through the bibliography will find no relevant sources.","section":"Full Text (references)"}],"recommendation":"reject","confidential_remarks":"This appears to be a submission mix-up: the abstract and the body are from two completely different papers. As a referee, I cannot evaluate a study whose methods and results are absent. If this is an upload error, the correct action may be to return the manuscript to the authors unrefereed so they can resubmit the intended paper; but as the current version stands, it must be rejected. The journal may wish to flag this case to the editorial office for a possible integrity check."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"You need to know two things about 2508.11063. The abstract describes a CT-based study of abdominal phenotypes across 1,728 adults with type 2 diabetes. The full text is an entirely different paper: a literature review of AI/LLM bias by Ghosh and Wilson from UW. There is no overlap in title, authors, or content.\n\nWhat the abstract promises is genuinely interesting: automated measurements of abdominal muscle fat, visceral/subcutaneous fat, pancreas size and fat, combined with random forest classification and SHAP-based clustering to define body-composition phenotypes separately in lean, overweight, and obese groups. The claim that abdominal drivers of diabetes are consistent across weight classes is plausible and clinically useful, if true. The design is reasonable, and the conclusion is appropriately worded.\n\nBut the evidence is absent. The submitted full text contains none of the CT imaging, cohort definitions, segmentation validation, cross-validation details, or statistical tests that the abstract reports. I cannot audit the methods or results. The reader's worry about measurement accuracy is legitimate, but it is secondary because the measurements themselves are not in the manuscript. The stress-test note is correct: this is not a stylistic inconsistency but a missing study.\n\nOn the abstract alone, the AUCs of 0.72-0.74 are moderate, and the univariate confirmations of 14-18 of the top 20 predictors are suggestive rather than definitive. Those would be worth probing if the real methods existed; they are moot here.\n\nWho is this for? Nobody, in this form. If the correct paper exists, it deserves a serious look from the medical-imaging and diabetes communities. But this submission cannot be reviewed. I would desk-reject it and ask the authors to resubmit the matching manuscript.","headline":"The abstract describes a CT/diabetes phenotype study, but the full text is an unrelated AI-bias literature review, so the central claim has no verifiable methods or results.","tokens_in":2751,"tokens_out":2503,"would_cite":false,"duration_ms":24076,"reading_group":"no","serious_thinker":"no","would_accept_peer_review":false},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"The abdominal drivers of type 2 diabetes are consistent across lean, overweight, and obese people.","keywords":["type 2 diabetes","abdominal body composition","computed tomography","random forest","Shapley values","visceral fat","pancreatic fat","phenotype discovery"],"falsifier":"A concrete check would be to compare the automated CT measurements against manual expert segmentations or quantitative imaging such as chemical-shift MRI in a sample that spans lean, overweight, and obese individuals. If the algorithm's estimates of pancreatic fat or muscle fat were systematically biased by weight class, the shared signatures could be artefacts rather than true biological patterns.","tokens_in":1904,"feed_emoji":"🩻","tokens_out":6371,"duration_ms":51741,"temperature":0.7,"pith_summary":"The paper asks whether the abdominal body-composition patterns linked to type 2 diabetes are the same in lean, overweight, and obese individuals, or whether weight class changes which measurements matter. To find out, the authors automatically extracted measurements of fatty skeletal muscle, visceral and subcutaneous fat, and pancreatic size and fat content from clinical CT scans of 1,728 people, then trained cross-validated random-forest classifiers to detect diabetes in the full cohort and in each weight group separately. The classifiers reached mean AUCs of 0.72–0.74, and their Shapley-value attributions pointed to the same set of drivers in every group: fatty muscle, more visceral and subcutaneous fat, older age, and a smaller or fat-laden pancreas. A univariate logistic-regression check confirmed the direction of 14–18 of the top 20 predictors within each subgroup. The paper concludes that abdominal drivers of type 2 diabetes may be consistent across weight classes.","feed_headline":"Abdominal drivers of diabetes are the same across weight classes","feed_subtitle":"Machine learning on CT scans finds the same abdominal markers in lean, overweight, and obese people.","key_machinery":"The working mechanism is a four-stage analysis pipeline. First, CT scans are segmented to turn anatomy into explainable measurements of muscle fat, visceral and subcutaneous fat, and pancreatic size and fat content. Second, a cross-validated random forest is trained to classify diabetes status from those measurements, in the full cohort and in each weight group. Third, a Shapley-value explanation technique attributes each model prediction back to the individual measurements, showing which features push risk up or down. Fourth, clustering on those attribution patterns groups scans by shared model-decision patterns, and classification links those groups back to anatomical differences. This design lets the authors compare which measurements are most influential within each weight class rather than merely comparing average values.","core_discovery":"The central claim is that the abdominal drivers of type 2 diabetes do not change with body-mass index, so the same body-composition abnormalities accompany diabetes whether a person is lean, overweight, or obese. Specifically, the paper reports that fatty skeletal muscle, greater visceral and subcutaneous fat, and a smaller or fattier pancreas are associated with diabetes risk in all three weight subgroups, together with older age. If this is right, then detailed abdominal imaging measures could serve as risk markers that work across the weight spectrum, and the biology connecting ectopic fat deposition to diabetes may operate similarly regardless of overall adiposity.","pith_inferences":["The consistency across weight classes could imply that interventions targeting visceral and muscle fat, such as exercise or medications, might benefit lean diabetic patients as much as obese ones, even though their BMI is normal.","A natural testable extension is a longitudinal study: measure these abdominal features in non-diabetic cohorts and see whether they predict progression to diabetes, which would separate risk markers from consequences of the disease.","Because the measurements come from routine CT scans, the pipeline could be applied retrospectively to large existing imaging archives, making the approach inexpensive to validate at scale.","The cross-sectional design cannot establish causality; the same signatures might be effects of diabetes or its treatment rather than pre-existing drivers."],"forward_implications":["If the drivers are consistent across weight classes, diabetes risk models do not need to be rebuilt separately for lean, overweight, and obese patients; a single set of abdominal imaging features may suffice.","Fatty skeletal muscle and pancreatic fat could serve as imaging markers that identify at-risk lean individuals who would be missed by BMI-based screening.","The confirmation of 14–18 of the top 20 predictors by univariate logistic regression suggests the signatures are robust to the choice of model.","The moderate AUCs of 0.72–0.74 imply these abdominal measurements are informative but not sufficient on their own, so they would likely complement clinical risk factors rather than replace them."],"supporting_citations":[],"fun_headline_variants":["Same belly fat markers predict diabetes in lean, overweight, and obese","Diabetes abdominal signals are identical across weight classes","CT scans show same diabetes belly markers from lean to obese","Identical abdominal fat signatures mark diabetes in all weights"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"The automated CT measurements of fatty muscle, visceral and subcutaneous fat, and pancreatic size and fat content are accurate and biologically meaningful enough to support the pattern discovery.","fun_headline_variants_meta":{"raw":{"variants":["Same belly fat markers predict diabetes in lean, overweight, and obese","Diabetes abdominal signals are identical across weight classes","CT scans show same diabetes belly markers from lean to obese","Identical abdominal fat signatures mark diabetes in all weights"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.001042,"raw_usage":{"total_tokens":4397,"prompt_tokens":973,"completion_tokens":3424,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":589,"completion_tokens_details":{"reasoning_tokens":3359}},"tokens_in":589,"tokens_out":3424,"duration_ms":22371,"temperature":1.0,"reasoning_tokens":3359,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-15T17:27:46.631633+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"A concrete check would be to compare the automated CT measurements against manual expert segmentations or quantitative imaging such as chemical-shift MRI in a sample that spans lean, overweight, and obese individuals. If the algorithm's estimates of pancreatic fat or muscle fat were systematically biased by weight class, the shared signatures could be artefacts rather than true biological patterns.","supporting_citations":[],"review_version":2}